NOTUS: FDA Will Reevaluate Fluoride Supplements, Says the Agency’s New Drug Director

“We’ve got to look at a risk-benefit analysis. And since this isn’t approved, it’s never been through the rigorous FDA process of saying there’s a benefit that outweighs the risk,” Tidmarsh told NOTUS about the fluoride supplements. “And if there’s not, then, you know, we should probably act.”